Medicare – Talk Bio

Trump pledges his support for a change to the IRA long sought by drugmakers

1 week ago talkbio0Tagged Biological Factors, Contraceptives, Oral, drug price, drugmakers, Industry, IRA, Mediation, Medicare, Prices

IRA, Medicare, Contraceptives, Oral, Mediation, Industry, drug price, Biological Factors, Prices, drugmakers, Medicare

Pharma’s wins and losses in Trump’s sprawling executive order on drug prices

1 week ago talkbio0Tagged drug price, Industry, Insulin, IRA, losses, Mediation, Medicare, Prices, small molecule drugs

Medicare, Medicare, Industry, drug price, Mediation, small molecule drugs, losses, IRA, Insulin, Prices

IRA round 2 begins as drugmakers sign on to price negotiation process with CMS

1 month ago talkbio0Tagged drugmakers, Ira (eukaryote), Mediation, Medicare, Myasthenic Syndromes, Congenital, Prices

Myasthenic Syndromes, Congenital, Mediation, Prices, Medicare, Ira (eukaryote), drugmakers

Drug Pricing and the Uncertain Future of the IRA Under Trump

2 months ago talkbio0Tagged Changing, drug price, IRA, Mediation, Medicare, Prices, repeal, Transplant Registry Unified Management Program, Uncertainty

IRA, Transplant Registry Unified Management Program, drug price, Medicare, Mediation, repeal, Changing, Uncertainty, Prices

Congressional Healthcare Reform Priorities Under Trump’s Second Term

3 months ago talkbio0Tagged Alcohol abuse, Medicaid block grants, Medicare, Prices, repeal, Translucent, Value-Based Care

ACA repeal, Medicaid block grants, price transparency, Medicare Advantage, drug pricing, value-based care

Medicare Selects Ozempic, Wegovy for Price Negotiations: A Step Towards Lowering Prescription Drug Costs

3 months ago talkbio0Tagged drug price, Health care facility, Inflation, Mediation, Medicare, Prescription procedure, seniors, Wegovy

Medicare, drug price negotiations, Ozempic, Wegovy, Inflation Reduction Act, prescription drug costs, seniors, healthcare.

Understanding the Second Round of Medicare Drug Price Negotiations: What Trump’s CMS Can and Can’t Change

3 months ago talkbio0Tagged Administration occupational activities, CMS, drug price, Inflation, Medicare, Myasthenic Syndromes, Congenital, negotiation, Prices, Transplant Registry Unified Management Program

Medicare drug price negotiation, Trump administration, CMS, Inflation Reduction Act, drug prices, negotiation process

Healthcare Sector Winners and Losers in the 2024 Government Funding Bill

4 months ago talkbio0Tagged Government, Health care facility, hospital-at-home programs, Legislation, Medicaid, Medicare, pay, Payments, Physicians, shutdown, Symmetrical dyschromatosis of extremities, Telemedicine

Healthcare funding, government shutdown, telehealth, Medicare payments, Medicaid DSH, hospital-at-home programs, physician pay cuts, healthcare legislation.

Congress Passes Slimmed-Down Continuing Resolution, Extends Telehealth Flexibilities and Includes PBM Reform

4 months ago talkbio0Tagged Continuous, Healthcare Package, Medicaid, Medicare, PBM Reform, physiologic resolution, Telehealth Flexibilities

Continuing Resolution, Telehealth Flexibilities, PBM Reform, Healthcare Package, Medicare, Medicaid

Healthcare M&A and IRA Price Negotiations: Key Trends to Watch Amidst Political Shifts

5 months ago talkbio0Tagged Acquisitions, Drug Industry, drug price, Healthcare M&A, Inflation, Ira (eukaryote), Mediation, Medicare, mergers, Negotiation Program, Prices, trends qualifier

Healthcare M&A, IRA Price Negotiations, Medicare Drug Price Negotiation Program, Inflation Reduction Act, Pharmaceutical Industry Trends, Mergers and Acquisitions Outlook 2024